Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Nasal Steroids for CGMS Skin Reactions in T1DM
NCT03594565Phase 1Completed
- Sponsor
- Shamir Medical Center
- Start
- Mar 2016
- Primary completion
- Jun 2017
- Modality
- Orthosteric Ligands
01
Overview
Phase 1, open-label, single-arm trial of fluticasone propionate in Contact dermatitis (CD), sponsored by Shamir Medical Center. Primary endpoint: Difference in skin irritation before and after regular application of nsFP according to the modified Draize scale at 2 years. Started Mar 2016; status: completed.
02
Drugs
fluticasone propionate
03
Conditions
Contact dermatitis (CD)
Beyond the preview
Go deeper on NCT03594565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03594565.